1,3,5-Tris((trimethylsilyl)ethynyl)benzene, 97%, 5g

N-(2-((4-Hydroxyphenyl)amino)pyridin-3-yl)-4-methoxybenzenesulfonamide, 98%, 50mg

Solution de gélatine ROTI®Cell

5-Bromo-2-ethoxypyridine, 98.0%, 1kg

2-Bromobenzeneboronic acid (contains varying amounts of anhydride), 95.0%, 25g

(R)-1-(5-Fluoropyridin-2-yl)ethanamine, 95.0%, 250mg

(S)-3-(4'-Benzyloxyphenyl)-2-hydroxy-propionic acid, 97.0%, 1g

2-Amino-2-(naphthalen-1-yl)acetic acid, 95.0%, 1g

Methyl-6-bromo picolinate, 95.0%, 1g

4-Amino-5-chloro-2,3-dihydrobenzofuran-7-carboxylic Acid>97.0%(HPLC)(T)200mg

[(1,3-Dioxoisoindolin-2-yl)methyl] methylcyanocarbonimidodithioate, 250mg

N-Boc-N-bis(PEG2-OH), 1g

2-Bromo-5-ethylthiophene, 95+%, 5g